As Henri Termeer, chief executive of Genzyme, a big biotechnology firm, argues, “the blockbuster model becomes less important over time as specialised therapies take off.”

就像大型生物技术公司健赞的首席执行官亨利·特米尔(Henri Termeer)所说，“随着时间的推移，个人化药物的推出，依靠拳头产品的商业模式变得越来越不重要了。”

youdao

"Thymoglobulin is an excellent product that has the potential to transform the way transplant teams manage the care of their patients, " said Genzyme Chief Executive Henri Termeer in a prepared statement.

FORBES: Magazine Article